Algernon Pharmaceuticals Reports Results of Study Showing 93% Cough Suppression with Ifenprodil

Stock Information for Algernon Pharmaceuticals Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Algernon Pharmaceuticals Inc.

Algernon Pharmaceuticals Announces Closing of Private Placement
Algernon Pharmaceuticals Announces Increase to Private Placement
Algernon Pharmaceuticals Announces Private Placement
Algernon Pharmaceuticals Announces Closing of Private Placement
Algernon Pharmaceuticals Announces Increase to Private Placement
Algernon Pharmaceuticals Announces Private Placement
Algernon Pharmaceuticals Engages ICP Securities Inc. for Automated Market Making Services
Algernon NeuroScience and the Centre for Human Drug Research to Present DMT Phase 1 Stroke Clinical Data at the Interdisciplinary Conference on Psychedelic Research June 6 - 8th, 2024

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.